Comparison of thiazide-like diuretics versus thiazide-type diuretics: a meta-analysis

Journal of Cellular and Molecular Medicine

Volumn 21, Issue 11, 2017, Pages 2634-2642

  Liang, Wenjing ^a   Ma, Hui ^b   Cao, Luxi ^c   Yan, Wenjiang ^a   Yang, Jingjing ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

hypertension; hypokalemia; hyponatremia; thiazide like diuretics; thiazide type diuretics

Indexed keywords

CHLORTALIDONE; CHOLESTEROL; ELECTROLYTE; GLUCOSE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

BLOOD LEVEL; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; INCIDENCE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; BLOOD; CHEMICALLY INDUCED; DRUG EFFECT; ELECTROLYTE BALANCE; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; CHLORTHALIDONE; CHOLESTEROL; DIURETICS; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; INDAPAMIDE; TREATMENT OUTCOME; WATER-ELECTROLYTE BALANCE;

EID: 85021266834     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.13205     Document Type: Review

References (29)

1. Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med. 2009; 361: 2153–64.
2. Messerli FH, Bangalore S. Half a century of hydrochlorothiazide: facts, fads, fiction, and follies. Am J Med. 2011; 124: 896–9.
3. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311: 507–20.
4. Tziomalos K, Athyros VG, Mikhailidis DP, et al. Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension. Curr Pharm Des. 2013; 19: 3766–72.
5. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension (Dallas, Tex: 1979). 2004; 43: 4–9.
6. Perry HM Jr, Smith WM, McDonald RH, et al. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke. 1989; 20: 4–13.
7. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991; 265: 3255–64.
8. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288: 2981–97.
9. Madkour H, Gadallah M, Riveline B, et al. Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am J Cardiol. 1996; 77: 23b–5b.
10. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358: 1887–98.
11. Bakris GL, Sica D, White WB, et al. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil. Am J Med. 2012; 125: 1229.e1-.e10.
12. Pareek A, Basavanagowdappa H, Zawar S, et al. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension. Expert Opin Pharmacother. 2009; 10: 1529–36.
13. Pareek A, Zawar SD, Salagre SB, et al. Antihypertensive efficacy of metoprolol XL/low dose chlorthalidone (6.25 mg) combination: a randomized, comparative study in indian patients with mild-to-moderate essential hypertension. Eur J Med Res. 2009; 14: 297–303.
14. Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension (Dallas, Tex: 1979). 2006; 47: 352–8.
15. Emeriau JP, Knauf H, Pujadas JO, et al. A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study. J Hypertens. 2001; 19: 343–50.
16. Spence JD, Huff M, Barnett PA. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison. Can J Clin Pharmacol. 2000; 7: 32–7.
17. Siegel D, Hulley SB, Black DM, et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 1992; 267: 1083–9.
18. Plante GE, Robillard C. Indapamide in the treatment of essential arterial hypertension: results of a controlled study. Curr Med Res Opin. 1983; 8(Suppl 3): 59–66.
19. Senior R, Imbs JL, Bory M, et al. Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study. J Cardiovasc Pharmacol. 1993; 22(Suppl 6): S106–10.
20. Radevski IV, Valtchanova ZP, Candy GP, et al. Comparison of indapamide and low-dose hydrochlorothiazide monotherapy in black patients with mild to moderate hypertension. S Afr Med J. 2002; 92: 532–6.
21. Kwon BJ, Jang SW, Choi KY, et al. Comparison of the efficacy between hydrochlorothiazide and chlorthalidone on central aortic pressure when added on to candesartan in treatment-naive patients of hypertension. Hypertens Res. 2013; 36: 79–84.
22. Pareek AK, Messerli FH, Chandurkar NB, et al. Efficacy of low-dose chlorthalidone and hydrochlorothiazide as assessed by 24-h ambulatory blood pressure monitoring. J Am Coll Cardiol. 2016; 67: 379–89.
23. Franse LV, Pahor M, Di Bari M, et al. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension (Dallas, Tex: 1979). 2000; 35: 1025–30.
24. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17: 1–12.
25. Mourad JJ, Le Jeune S. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients. Curr Med Res Opin. 2009; 25: 2271–80.
26. Gosse P. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection. Expert Rev Cardiovasc Ther. 2006; 4: 319–33.
27. Peterzan MA, Hardy R, Chaturvedi N, et al. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension (Dallas, Tex: 1979). 2012; 59: 1104–9.
28. Olde Engberink RH, Frenkel WJ, van den Bogaard B, et al. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis. Hypertension (Dallas, Tex: 1979). 2015; 65: 1033–40.
29. van Blijderveen JC, Straus SM, Rodenburg EM, et al. Risk of hyponatremia with diuretics: chlorthalidone versus hydrochlorothiazide. Am J Med. 2014; 127: 763–71.